China Pharma Holdings

CPHI · NYSE American

$0.7101−$0.0143 (−1.97%)TodayMarket open · Oct 21, 11:16 AM ET · Delayed 15 min

Prev close $0.7243

About CPHI

China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.

Employees: 224
Headquarters: Haikou, Hainan
Listed: Feb 15, 2000
Sector: Health Care
Industry: Pharmaceuticals
Website: chinapharmaholdings.com

Leadership

China Pharma Holdings executives
Name	Title	Since	Age
Zhilin Li	—	2005	68
Heung Tsui	—	—	64
Gene Bennett	—	—	73
Baowen Dong	—	—	80
Yingwen Zhang	—	—	76

Revenue by product and region

Fiscal year ended Dec 31, 2020: $10.87M total revenue

By product

Domestic Pharmaceuticals [Member]$9.13M84.0%
COVID 19 Testers [Member]$1.73M16.0%

Similar companies

Companies in the same industry as China Pharma Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.